Matthew James Spindler
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2018First federal award
$355KFederal grants as PI2 awards
2Patents grantedLatest Dec 16, 2025
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
2 awards · $355K
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| May 3, 2023 | NIH | SBIR Phase I Engineered TCR-Treg Cell Therapies Targeting Type 1 Diabetes Autoantigens | $55K | GIGAMUNE, INC. |
| Sep 5, 2018 | NIH | SBIR Phase I Recombinant TIL Cell Therapy for Salvage Solid Tumor Patients | $300K | GIGAMUNE, INC. |
3 patents as inventor
- US 11421220GIGAMUNE, INC.Aug 23, 2022
- US 12497711GIGAMUNE, INC.Dec 16, 2025
- US GIGAMUNE, INC.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#2,747
Awards as PI#1,252
Patents#102
Companies
- GIGAMUNE, INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.